Biomimetic calcium phosphate/polyelectrolyte multilayer coatings for sequential delivery of multiple biological factors

J Biomed Mater Res A. 2017 May;105(5):1500-1509. doi: 10.1002/jbm.a.35985. Epub 2017 Mar 20.

Abstract

Combinations of growth factors synergistically enhance tissue regeneration, but typically require sequential, rather than co-delivery from biomaterials for maximum efficacy. Polyelectrolyte multilayer (PEM) coatings can deliver multiple factors without loss of activity; however, sequential delivery from PEM has been limited due to interlayer diffusion that results in co-delivery of the factors. This study shows that addition of a biomimetic calcium phosphate (bCaP) barrier layer to a PEM coating effectively prevents interlayer diffusion and enables sequential delivery of two different biomolecules via direct cell access. A simulated body fluid method was used to deposit a layer of bCaP followed by 30 bilayers of PEM made with poly-l-Lysine (+) and poly l-Glutamic acid (-) (bCaP-PEM). Measurements of MC3T3-E1 proliferation and viability over time on bCaP-PEM were used to demonstrate the sequential delivery kinetics of a proliferative factor [fibroblast growth factor-2 (FGF-2)] followed by a cytotoxic factor (antimycin A, AntiA). FGF-2 and AntiA both retained their bioactivity within bCaP-PEM, yet no release of FGF-2 or AntiA from bCaP-PEM was observed when cells were absent indicating a cell-mediated, local delivery process. This coating technique is useful for a variety of applications that would benefit from highly localized, sequential delivery of multiple biomolecules governed by cell initiated degradation that avoids off-target effects associated with diffusion-based release. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 1500-1509, 2017.

Keywords: biomaterial; calcium phosphate; fibroblast growth factor-2; multifactor delivery; polyelectrolyte multilayer films.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antimycin A* / chemistry
  • Antimycin A* / pharmacokinetics
  • Antimycin A* / pharmacology
  • Biomimetic Materials* / chemistry
  • Biomimetic Materials* / pharmacokinetics
  • Biomimetic Materials* / pharmacology
  • Calcium Phosphates* / chemistry
  • Calcium Phosphates* / pharmacokinetics
  • Calcium Phosphates* / pharmacology
  • Cell Line
  • Cell Proliferation / drug effects
  • Coated Materials, Biocompatible* / chemistry
  • Coated Materials, Biocompatible* / pharmacokinetics
  • Coated Materials, Biocompatible* / pharmacology
  • Drug Delivery Systems / methods*
  • Fibroblast Growth Factor 2* / chemistry
  • Fibroblast Growth Factor 2* / pharmacokinetics
  • Fibroblast Growth Factor 2* / pharmacology
  • Mice
  • Polyelectrolytes* / chemistry
  • Polyelectrolytes* / pharmacokinetics
  • Polyelectrolytes* / pharmacology

Substances

  • Calcium Phosphates
  • Coated Materials, Biocompatible
  • Polyelectrolytes
  • Fibroblast Growth Factor 2
  • Antimycin A
  • calcium phosphate